may PAY $25 for
Tris ADHD products
What is ADHD?
ADHD is a neurodevelopmental disorder that affects both children and adults. ADHD is most often diagnosed during childhood, but the disorder may continue into adulthood in most cases.1
What are the symptoms of ADHD?
Some common symptoms of ADHD include inattention, hyperactivity, and impulsivity. According to the DSM-V, ADHD typically presents in 1 of 3 ways2:
(formerly known as attention-deficit disorder, or ADD)
Is there a cure for ADHD?
While there is no scientifically proven cure for ADHD, most treatment plans include a combination of behavior therapy and medication to help manage the symptoms of ADHD.1 Treatment success can vary by patient and family. Read about Tris Pharma treatments for patients 6 years and older with ADHD, including:
Is there a genetic link?
Research to date has shown that ADHD is a biological condition with several possible causes, including genetics.1
Who else should be screened when a patient has been diagnosed with ADHD?
If you have diagnosed a young patient with ADHD, you may consider screening their parents and siblings for ADHD.3
If you have diagnosed an adult patient with ADHD, you may consider screening their children, if any.3 Learn more about ADHD with resources available to you and your patients.
What are the categories of ADHD treatments?
There are many options available for treating ADHD in children and adult patients. Stimulant medications are often used in the treatment of patients with ADHD. There are 2 types of stimulants4:
- Methylphenidate: a CNS stimulant believed to work by blocking the reuptake of dopamine from the synaptic cleft
- Amphetamine: a CNS stimulant believed to work by increasing availability of norepinephrine and dopamine at the synaptic cleft
Knowing the difference between the 2 is key in determining which treatment is appropriate for your patient. While responses to methylphenidate and to amphetamine in patients with ADHD are generally similar, patients may respond very differently to the 2 classes of stimulants. If a patient has an unsatisfactory response to 1 class, prescribing the other class is recommended, as the proportion of patients who respond to 1 of the drugs may be as high as 95%.5
Do methylphenidate and amphetamine have the same mechanism of action?
Methylphenidate and amphetamine are both stimulants and are often used interchangeably to treat ADHD, but they have distinct mechanisms of action. Because they affect dopamine and norepinephrine differently, patients may respond differently to each.4
Is a methylphenidate or an amphetamine right for my patient?
Deciding whether to prescribe a methylphenidate such as Quillivant XR or QuilliChew ER, or an amphetamine such as DYANAVEL XR tablet or DYANAVEL XR oral suspension, depends largely on the individual needs of the patient, prior patient response or lack of response to methylphenidate or amphetamine, patient preference for liquid vs tablet formulation, and any other conditions the patient may have.
Prior to treatment with Quillivant XR, QuilliChew ER, or DYANAVEL XR, patients should be assessed for the presence of cardiac disease and risk of abuse. During treatment, careful prescription records should be maintained, and patients should be informed about abuse and monitored for signs of abuse and overdose. The need for continued stimulant medication use should be periodically reevaluated and, if necessary, dosage reduced or treatment discontinued.
Choose the Tris portfolio of ADHD products,
designed to help meet your patients' individual needs
Tris Pharma offers amphetamine and methylphenidate treatment options for patients
6 years and older with ADHD. Select a product below.
Help your patients save on Tris ADHD products.
CNS, central nervous system; DSM-V, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.
References: 1. Centers for Disease Control and Prevention. Updated September 23, 2021. Accessed May 26, 2022. https://www.cdc.gov/ncbddd/adhd/facts.html 2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Publishing; 2013. 3. Mayo Clinic. Updated June 25, 2019. Accessed May 26, 2022. https://www.mayoclinic.org/diseases-conditions/adult-adhd/symptoms-causes/syc-20350878 4. Shier AC, Reichenbacher T, Ghuman HS, Ghuman JK. J Cent Nerv Syst Dis. 2013;5:1-17. 5. Hodgkins P, Shaw M, Coghill D, Hechtman L. Eur Child Adolesc Psychiatry. 2012;21(9):477-492.